BIOABIOANASDAQ

Revenue (LTM)

Net Income (LTM)

$-71M

-11.4% YoY

Free Cash Flow

$-52M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.1B)

Unprofitable

Metric	Dec 22	Dec 23	Dec 24
Revenue	0	0	0
Gross Profit	0	0	0
Operating Income	-40	-48↓21.1%	-78↓61.6%
Net Income	-40	-64↓60.8%	-71↓11.4%
EBITDA	-39	-56↓42.0%	-69↓22.7%
EPS Diluted	-5.32	-8.55↓60.7%	-6.63↑22.5%

Metric	Dec 22	Dec 23	Dec 24
Cash & Equivalents	28	22↓21.7%	354↑1537.2%
Total Current Assets	28	25↓9.7%	357↑1311.1%
Total Assets	28	26↓8.8%	358↑1281.9%
Total Current Liabilities	6	58↑892.5%	28↓52.3%
Total Liabilities	141	199↑41.4%	35↓82.4%
Total Equity	-113	-173↓54.0%	323↑286.4%
Total Debt	2	53↑2057.7%	9↓83.7%
Net Debt	-25	32↑225.5%	-346↓1193.5%

Metric	Dec 22	Dec 23	Dec 24
Operating Cash Flow	-36	-37↓3.3%	-52↓37.9%
Capital Expenditure	-0	-0↓61.2%	-0↓120.5%
Free Cash Flow	-36	-38↓3.4%	-52↓38.3%
Stock-Based Comp	3	3↑18.7%	7↑131.4%
Net Change in Cash	-34	-3↑92.0%	329↑12358.7%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance